Pricing

Laverock Therapeutics

0 followers

‌

Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.

Industries

Biotechnology, Therapeutics

Employees

11-50

Links

Org chart

David Venables

CEO

David Venables

Collapse

John Brown

Non Executive Director

Sandy McDougall

Chief Financial Officer

Tim Allsopp

CTO

Tom Payne

Chief Operating Officer

Vlad Seitan

Chief Scientific Officer

Teams

Research and Development

7 members

Leadership Team

6 members

Similar companies

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Halda Therapeutics

1 follower

Artiva Biotherapeutics

1 follower

Thermo Fisher Scientific

158 followers

CRISPR Therapeutics

9 followers

Adverum Biotech

8 followers

Legend Biotech

5 followers

Roche

238 followers

Verve Therapeutics

54 followers

Artivion

3 followers

Explore companies